Debate over dexfenfluramine.
作者信息
Deitel M
出版信息
CMAJ. 1997 Jul 1;157(1):14, 16.
Abstract
摘要
相似文献
1
Debate over dexfenfluramine.关于右芬氟拉明的争论。
CMAJ. 1997 Jul 1;157(1):14, 16.
2
Appetite suppressants and pulmonary hypertension: a long-term risk.食欲抑制剂与肺动脉高压：一项长期风险。
Prescrire Int. 2006 Oct;15(85):183.
3
Appetite-suppressant drugs and the risk of primary pulmonary hypertension?
Obes Surg. 1997 Feb;7(1):3-4. doi: 10.1381/096089297765556114.
4
Primary pulmonary hypertension and long-term use of appetite suppressants.
CMAJ. 1997 Jan 1;156(1):89-90, 93-4.
5
Obesity, dexfenfluramine, and pulmonary hypertension. A lesson not learned?肥胖、右芬氟拉明与肺动脉高压。这个教训仍未被吸取？
Am J Respir Crit Care Med. 1997 Mar;155(3):786-8. doi: 10.1164/ajrccm.155.3.9117009.
6
High altitude may be synergistic with pulmonary hazards of appetite control medications fenfluramine and dexfenfluramine.高海拔可能与食欲控制药物芬氟拉明和右芬氟拉明的肺部危害具有协同作用。
Med Hypotheses. 1997 Dec;49(6):509-12. doi: 10.1016/s0306-9877(97)90070-0.
7
Dexfenfluramine, fenfluramine, and phentermine for the treatment of morbid obesity.右芬氟拉明、芬氟拉明和苯丁胺用于治疗病态肥胖。
J Am Acad Nurse Pract. 1997 Aug;9(8):389-94, quiz 395-7. doi: 10.1111/j.1745-7599.1997.tb01261.x.
8
[The French are wary of their drugs].法国人对他们的药品持谨慎态度。
Rev Med Suisse. 2011 May 25;7(296):1170-1.
9
Appetite-suppressant drugs and primary pulmonary hypertension.食欲抑制药物与原发性肺动脉高压
N Engl J Med. 1997 Feb 13;336(7):511; author reply 512-3.
10
[Pulmonary hypertension following use of appetite depressants?].[使用食欲抑制剂后出现肺动脉高压？]
Med Klin. 1974 Feb 1;69(5):211.
引用本文的文献
1
Absence of fenfluramine-induced anorexia and reduced c-Fos induction in the hypothalamus and central amygdaloid complex of serotonin 1B receptor knock-out mice.氟苯丙胺诱导的厌食症缺失以及血清素1B受体基因敲除小鼠下丘脑和中央杏仁核复合体中c-Fos诱导减少。
J Neurosci. 1998 Jul 15;18(14):5537-44. doi: 10.1523/JNEUROSCI.18-14-05537.1998.
Zotero 插件